NASDAQ:MDTH - MedCath Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About MedCath (NASDAQ:MDTH)

MedCath Corporation (MedCath) is a healthcare provider and focused on providing acuity services, including the diagnosis and treatment of cardiovascular disease. The Company owns and operates hospitals in partnership with physicians. Each of its majority-owned hospitals provides a range of health services with a focus on cardiovascular care. Each of its hospitals has around the clock-hour emergency room staffed by emergency department physicians. As of September 30, 2010, it owed interests in seven hospitals, including six in which it owned a majority interest. On November 1, 2010, the Company sold Heart Hospital of Austin. On December 31, 2010, the Company completed the sale of TexSan Heart Hospital to Methodist Healthcare System of San Antonio. On September 30, 2011, the Company sold Louisiana Medical Center & Heart Hospital to Cardiovascular Care Group. In December 2011, the Company announced that it has sold its ownership interest in Harlingen Medical Center and HMC Realty, LLC.

Receive MDTH News and Ratings via Email

Sign-up to receive the latest news and ratings for MDTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

MedCath (NASDAQ:MDTH) Frequently Asked Questions

What is MedCath's stock symbol?

MedCath trades on the NASDAQ under the ticker symbol "MDTH."

Has MedCath been receiving favorable news coverage?

News coverage about MDTH stock has been trending somewhat positive on Tuesday, Accern reports. Accern identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MedCath earned a news sentiment score of 0.09 on Accern's scale. They also assigned media stories about the health services provider an impact score of 46.42 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of MedCath?

Shares of MDTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MedCath?

MedCath's mailing address is Corporation Trust Center 1209 Orange Street, New Castle County, WILMINGTON, DE 19801, United States. The health services provider can be reached via phone at +1-302-6587581.

MarketBeat Community Rating for MedCath (MDTH)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about MedCath and other stocks. Vote "Outperform" if you believe MDTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDTH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedCath (NASDAQ:MDTH) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/22/2016 forward)


MedCath (NASDAQ:MDTH) Earnings History and Estimates Chart

Earnings by Quarter for MedCath (NASDAQ:MDTH)

MedCath (NASDAQ MDTH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/14/2011Q4 2011$0.06($0.36)ViewN/AView Earnings Details
8/9/2011($0.02)($0.03)ViewN/AView Earnings Details
5/9/2011Q2 2011$0.06$0.02ViewN/AView Earnings Details
2/9/2011$0.03($0.28)ViewN/AView Earnings Details
11/23/2010Q4 2010$0.02ViewN/AView Earnings Details
8/9/2010Q3 2010$0.05$0.03ViewN/AView Earnings Details
5/5/2010Q2 2010($0.02)$0.06ViewN/AView Earnings Details
2/3/2010Q1 2010($0.03)($0.11)ViewN/AView Earnings Details
11/11/2009Q4 2009$0.12$0.03ViewN/AView Earnings Details
8/5/2009Q3 2009$0.21$0.21ViewN/AView Earnings Details
5/21/2009Q2 2009$0.23$0.29ViewN/AView Earnings Details
2/4/2009Q1 2009$0.16$0.15ViewN/AView Earnings Details
11/13/2008Q4 2008$0.27$0.12ViewN/AView Earnings Details
8/7/2008Q3 2008$0.36$0.27ViewN/AView Earnings Details
5/6/2008Q2 2008$0.26$0.30ViewN/AView Earnings Details
2/7/2008Q1 2008$0.29$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


MedCath (NASDAQ:MDTH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MedCath (NASDAQ MDTH) Insider Trading and Institutional Ownership History

Insider Trading History for MedCath (NASDAQ:MDTH)

MedCath (NASDAQ MDTH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


MedCath (NASDAQ MDTH) News Headlines

No headlines for this company have been tracked by

SEC Filings

MedCath (NASDAQ:MDTH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


MedCath (NASDAQ:MDTH) Income Statement, Balance Sheet and Cash Flow Statement


MedCath (NASDAQ MDTH) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.